Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Guardion Health Sciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q3 2022
- Shares held
- 3.75M
- −1.03M (−21.6%) vs. Q3 2022
- Total value
- $545.8K
- −$113.2K (−17.2%) vs. Q3 2022
- New holders
- 4
- 3 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 15 | $587.7K |
| Q2 2024 | 12 | $674.9K |
| Q1 2024 | 12 | $595.0K |
| Q4 2023 | 11 | $347.9K |
| Q3 2023 | 14 | $497.7K |
| Q2 2023 | 13 | $387.4K |
| Q1 2023 | 10 | $314.5K |
| Q4 2022 | 22 | $545.8K |
| Q3 2022 | 23 | $659.0K |
| Q2 2022 | 22 | $654.3K |
| Q1 2022 | 20 | $1.09M |
| Q4 2021 | 20 | $1.61M |
| Q3 2021 | 19 | $3.82M |
| Q2 2021 | 16 | $4.80M |
| Q1 2021 | 14 | $4.14M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Guardion Health Sciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 1,670,750 | $242.0K | 0.00% | −53,200−3.1% | Reduced |
| BlackRock Inc. | 501,454 | $72.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 288,281 | $41.8K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 250,000 | $36.3K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 196,476 | $29.0K | 0.00% | −620,421−75.9% | Reduced |
| Geode Capital Management, LLC | 169,865 | $25.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 152,585 | $22.9K | 0.00% | −110.0% | Reduced |
| State Street Corp | 134,934 | $19.6K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 117,507 | $17.1K | 0.00% | −175,133−59.8% | Reduced |
| Northern Trust Corp | 57,649 | $8.37K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 44,945 | $7.00K | 0.00% | +6,371+16.5% | Added |
| Citadel Advisors LLC | 46,871 | $6.80K | 0.00% | +46,871 | New |
| Morgan Stanley | 33,136 | $4.81K | 0.00% | +14,210+75.1% | Added |
| Jane Street Group, LLC | 27,761 | $4.03K | 0.00% | +27,761 | New |
| HRT Financial LP | 22,005 | $3.00K | 0.00% | +22,005 | New |
| Citigroup Inc | 18,617 | $2.70K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 15,000 | $2.18K | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 36 | $252 | 0.00% | +36 | New |
| Signaturefd, LLC | 996 | $145 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 834 | $121 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 420 | $61 | 0.00% | +11+2.7% | Added |
| Advisor Group Holdings, Inc. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −137,705−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −79,277−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −44,856−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −25,164−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −13,705−100.0% | Sold out |